China Dismisses US Tariff Threats as Trade Tensions Escalate

Thu 17th Apr, 2025

China has firmly stated that it will not heed the United States' escalating threats regarding tariffs, with the Chinese Foreign Ministry expressing its discontent over recent announcements from the White House. The US has indicated that China could face punitive tariffs as high as 245% in response to its retaliatory measures.

In a related development, former President Donald Trump described his discussions with a Japanese trade delegation as a significant advancement. Engaging directly in the talks, Trump met with Japanese Minister of Economy, Trade and Industry Ryosei Akazawa, which took many by surprise. The Japanese side had initially expected a more exploratory engagement rather than direct involvement from Trump himself. Minister Akazawa emphasized the need for the removal of existing tariffs imposed by the Trump administration, signaling Japan's intent to strengthen trade relations with the US.

As the situation unfolds, US stock markets have reacted negatively to comments made by Jerome Powell, the Chairman of the Federal Reserve, who warned of a bleak economic outlook. The Dow Jones Industrial Average dropped by 1.73%, with tech-heavy indices like the Nasdaq experiencing even steeper declines. Notably, shares of Nvidia fell nearly 11%, impacted by export restrictions to China and rising production costs within the US.

Powell acknowledged signs of economic slowdown in the US, particularly in the first quarter. He noted that while the economy remains solid, the effects of tariffs imposed during Trump's presidency could be more severe than previously anticipated. He suggested that the Federal Reserve might maintain current interest rates to await clearer economic indicators before making adjustments.

The potential consequences of these tariffs also extend to international trade dynamics. A report from Deloitte indicated that German pharmaceutical exports to the US could be halved due to the ongoing trade tensions. The American market is vital for the German pharmaceutical industry, and such a decline in exports could result in revenue losses amounting to EUR13.4 billion over the next few years.

Furthermore, António Costa, President of the European Council, cautioned against harsh retaliatory measures in the ongoing tariff dispute with the US. He emphasized the importance of the trade relationship between the EU and the US, which constitutes 40% of global economic output, and advocated for negotiations to avert a trade war. The French government has taken a bolder stance, suggesting that major US tech firms should be targeted in response to the tariffs.

The situation remains fluid as various stakeholders, including the European Union and individual countries, weigh their responses to the evolving trade landscape. The WTO has projected a 1.5% decline in global trade volumes this year, primarily affecting North America while also warning of potential rerouting of Chinese exports to Europe.

In the face of these developments, California Governor Gavin Newsom announced plans to file a lawsuit against Trump's tariffs, which he claims are causing chaos for families and businesses in the state. Newsom contended that such tariffs must be approved by Congress and criticized their arbitrary implementation, which he views as both troubling and illegal.

As the economic implications of the tariffs unfold, companies across sectors are bracing for the impact. For instance, the German laboratory and pharmaceutical supplier Sartorius expressed confidence in managing potential disruptions due to tariffs, citing a well-established international production network, including facilities in the US.

Overall, the trade conflict between the US and China continues to escalate, with significant implications for global markets, international relationships, and economic stability.


More Quick Read Articles »